Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

The m6A reader IGF2BP1 attenuates the stability of RPL36 and cell proliferation to mediate benzene hematotoxicity by recognizing m6A modification
Jingyu Wang, Xiaoli Guo, Yujiao Chen, et al.
Toxicology (2024) Vol. 503, pp. 153758-153758
Closed Access | Times Cited: 4
The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases
Xudong Wu, Hui Chen, Kai Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
METTL Family in Healthy and Disease
Jiejie He, Fengchen Hao, Shiqi Song, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Functions of METTL1/WDR4 and QKI as m7G modification - related enzymes in digestive diseases
Wenyan Zhou, Yan Yi, Wenyu Cao, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
The interplay between RNA m<sup>6</sup>A modification and radiation biology of cancerous and non-cancerous tissues: a narrative review
Yajia Cheng, Yue Shang, S. Zhang, et al.
Cancer Biology and Medicine (2025) Vol. 21, Iss. 12, pp. 1120-1140
Open Access
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
miR-378d suppresses gastric cancer metastasis by targeting METTL4 to inhibit epithelial-mesenchymal transition
Dajun Xing, Jiapeng Bao, Jiancheng He, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
The emerging significance of the METTL family as m6A-modified RNA methyltransferases in head and neck cancer
Ming Yang, Zile Zhang, Hao Qin, et al.
Cellular Signalling (2025), pp. 111798-111798
Closed Access
N6-methyladenosine (m6A) modification in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116365-116365
Open Access | Times Cited: 3
METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor
Xin Chen, Miaomiao Wang, Haoran Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117366-117366
Open Access | Times Cited: 3
METTL protein family: focusing on the occurrence, progression and treatment of cancer
Huhu Zhang, Fulin Sun, Shuyao Jiang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
METTL16 regulates the mRNA stability of FBXO5 via m6A modification to facilitate the malignant behavior of breast cancer
Runying Wang, Xingjie Gao, Luhan Xie, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Methyl-Transferase-Like Protein 16 (METTL16): The Intriguing Journey of a Key Epitranscriptomic Player Becoming an Emerging Biological Target
Simona Barone, Carmen Cerchia, Vincenzo Summa, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14786-14806
Closed Access | Times Cited: 2
SOX7 inhibits the malignant progression of bladder cancer via the DNMT3B/CYGB axis
Jingcheng Zhang, Wentao Zhang, Liu Ji, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
Up-regulation of RNA m6A methyltransferase like-3 expression contributes to arsenic and benzo[a]pyrene co-exposure-induced cancer stem cell-like property and tumorigenesis
Zhishan Wang, Mohammad B. Uddin, Po‐Shun Wang, et al.
Toxicology and Applied Pharmacology (2023) Vol. 481, pp. 116764-116764
Open Access | Times Cited: 4
METTL16 in human diseases: What should we do next?
Hui Zhang, Mengqi Yin, Hua Huang, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
M6A reader YTHDF1 promotes malignant progression of laryngeal squamous carcinoma through activating the EMT pathway by EIF4A3
Huina Guo, Qi Han, Xiaoya Guan, et al.
Cellular Signalling (2023) Vol. 114, pp. 111002-111002
Closed Access | Times Cited: 4
Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer
Y Zhang, Yufeng Ling, Ying Zhou, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 1
METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth
Shaojie Wu, Hua Wang, Qixuan Yang, et al.
Cancer Letters (2024) Vol. 597, pp. 217058-217058
Closed Access | Times Cited: 1
Decoding the role of tRNA modifications in cancer progression
Riley O. Hughes, Hannah J Davis, Leona Nease, et al.
Current Opinion in Genetics & Development (2024) Vol. 88, pp. 102238-102238
Closed Access | Times Cited: 1
Methyltransferase-Like 3–Driven N6-Methyladenosine Modification of RBPJ Promotes Vascular Remodeling in Pulmonary Hypertension
Qiang Du, Chun Zhang, Tianyu Qu, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 12, pp. 2252-2271
Closed Access | Times Cited: 1
Decoding the molecular symphony: interactions between the m6A and p53 signaling pathways in cancer
Rachel Shoemaker, Mo-Fan Huang, Ying-Si Wu, et al.
NAR Cancer (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Decoding the epitranscriptome: a new frontier for cancer therapy and drug resistance
Lu Tang, Hua Tian, Min Qi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
N6-methyladenosine modification of circular RNA circASH2L suppresses growth and metastasis in hepatocellular carcinoma through regulating hsa-miR-525-3p/MTUS2 axis
Da-Feng Xu, Yachong Liu, Qiumeng Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Targeting methyltransferase-like 5-mediated sphingomyelin metabolism: A novel therapeutic approach in gastric cancer
Jinjuan Zhang, Chang Yuan, Sheng-Chun Dang
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 10, pp. 4060-4063
Closed Access

Scroll to top